Claim OwnershipRadio Advisory
Subscribed: 118,415Played: 377,249
Subscribe
© 2025 Advisory Board
Description
A top podcast for healthcare leaders, with over one million downloads, Radio Advisory is your weekly download on how to untangle the industry's most pressing challenges to help leaders like you make the best business decisions for your organization.
From unpacking major trends in care delivery—like site-of-care shifts and the rise of high-cost drugs—to demystifying stakeholder dynamics, to shining a spotlight on priorities that may get overlooked, we're here to help. Our hosts and seasoned researchers talk with industry experts to equip you with knowledge to confront today's unanswered questions in healthcare. New episodes drop every Tuesday. | www.advisory.com
From unpacking major trends in care delivery—like site-of-care shifts and the rise of high-cost drugs—to demystifying stakeholder dynamics, to shining a spotlight on priorities that may get overlooked, we're here to help. Our hosts and seasoned researchers talk with industry experts to equip you with knowledge to confront today's unanswered questions in healthcare. New episodes drop every Tuesday. | www.advisory.com
265 Episodes
Reverse
The federal drug purchasing program known as 340B was created in 1992 to help select provider organizations stretch scarce resources to care for patients. More than three decades later, health systems of all shapes and sizes have come to rely on 340B for their financial sustainability. But the program has come under criticism. And in recent years, it’s been under more scrutiny, with manufacturers, state governments, and federal regulators proposing changes to how it operates. In this episode, host Abby Burns invites Advisory Board experts Gina Lohr and Chloe Bakst to unpack the origin and controversy around 340B. They debate whether 340B has strayed from its intended purpose and break down the proposed changes to the program, how likely they are to go into effect, and what those changes would mean for health systems. Plus, stay tuned to the end of the episode, where co-host Rae Woods discusses the recent healthcare-focused executive order and what it signals for the future of this administration’s drug policy. Let us know what you think about today’s discussion, or share your ideas for future episode topics by leaving us a voice message or emailing us. Links: 340B Drug Pricing Program 340B reimbursement cuts may be looming: What you need to know J&J's 340B rebate model is receiving pushback. Here's why. Congress is weighing spending cuts. How will they impact healthcare? [Relentless Health Value] EP448 (Part 1): 340B: Where It Started, Where It Is Now, and Who Is Really Benefiting From This Massive Program, With Shawn Gremminger [Relentless Health Value] EP448 (Part 2): 340B: Why Employers Should Probably Care About What’s Happening Here, With Shawn Gremminger GLP-1 innovation showcase A transcript of this episode as well as more information and resources can be found on RadioAdvisory.advisory.com.
In 2025, 6% of US adults are taking a GLP-1. But the popularity of weight-loss drugs isn’t the only thing changing the obesity care landscape. On Radio Advisory, we’ve talked about what comprehensive obesity care looks like, the reality of weight bias, and the strain high-cost drugs like GLP-1s are having on employers and plans. But we haven’t done an updated scan of the obesity care landscape, until now. To share the state of the Obesity market in 2025, host Rachel (Rae) Woods invites Advisory Board experts Gaby Marmolejos and Madeline Vogel to share the latest on bariatric surgery volumes, coverage decisions, patient preferences, drug shortages, compounding, and the new competitive landscape for direct-to-consumer obesity care. Given the pace of change in just a few short years, Rae also invites her guests make predictions about the obesity market two years from now. Links: Ep. 159: Ozempic, Wegovy, and our questions on weight management drugs Ep. 222: It's not just GLP-1s; here's what comprehensive weight management looks like Diabetes and obesity care growth forecast: What you need to know GLP-1 innovation showcase 2025 Nursing Survey Upcoming Webinar: Obesity market trends and forecasts A transcript of this episode as well as more information and resources can be found on RadioAdvisory.advisory.com.
Let’s face it: Hospitals and post-acute providers can find themselves at odds. Post-acute is an area of the industry that is often misunderstood and sometimes villainized. But when post-acute care struggles, it directly impacts hospital operations. The industry needs a solution. It starts with understanding that the post-acute space is not a monolith. Because only by understanding how different facilities struggle—and how systems can support or partner with them—can we unlock their potential. That’s why this week, host Abby Burns invites Advisory Board expert Monica Westhead, and Optum Advisory post-acute care expert Jennifer Skaggs to unpack the post-acute landscape and break down what effective acute-post-acute partnerships looks like. Throughout the discussion, they explore why post-acute facilities are struggling to stay afloat, and why partnering with post-acute facilities is better avenue than building or buying. Links: The Playbook for Hospital/Post-Acute Care Collaboration Optum Advisory partners with hospitals nationwide to improve efficiency and optimize resource utilization to reduce labor expenses. New staffing mandates for SNFs will have broad effects. Here's how to prepare. Post-acute care Landing Page 2025 Nursing Survey A transcript of this episode as well as more information and resources can be found on RadioAdvisory.advisory.com.
Every stakeholder in healthcare is getting squeezed by mounting financial pressures, and health plans are no exception. Higher utilization and rising treatment costs are hitting plans hard. At the same time, plans are facing heightened public scrutiny. It may seem like the wrong time for plans to focus on cost management, but the combination of market and public pressures is exactly why it is so important for plans to get a handle on their clinical costs. If not, they risk passing those costs on to employers or members. The good news is, health plans already have a comprehensive playbook for managing their clinical costs. The bad news is, these strategies don’t often take a targeted approach. This week, host Rachel (Rae) Woods invites Advisory Board experts Chelsea Needham, Morghen Philippi, and Rhea Jain to unpack how plans should think about tailoring their approach to cost management, how leaders can deploy their tools with greater precision, and why plans’ actions in this space will impact healthcare stakeholders across the board. Stay tuned to the end of the episode, where co-host Abby Burns provides an update on the recent layoffs and restructuring of HHS, and the near and long-term impacts of the shakeup. Let us know what you think about today’s discussion, or share your ideas for future episode topics by leaving us a voice message or emailing us. Links: 5 care navigation strategies to help employers cut healthcare costs 3 strategies for sustainable health plan growth Health plan utilization management Learn more about the key features and benefits of Optum Integrity One™, and how it can transform your revenue cycle Q&A with iRhythm Technologies: The importance of arrhythmia detection A transcript of this episode as well as more information and resources can be found on RadioAdvisory.advisory.com.
It feels like only yesterday that workforce challenges were the biggest problem facing the healthcare industry. While COVID-19-related staffing shortages may have declined, an inefficient workforce can still threaten health system operations and finances. Often, systems turn to staffing ratios or benchmarks to determine whether they need more cuts or more hires. However, systems need more than staffing ratios to make sure they have the right headcount and the right expertise in place to safely and effectively care for patients. The question is: if workforce benchmarks aren’t enough, then what is? To answer that question, host Rachel (Rae) Woods invites Advisory Board nursing expert Ali Knight to unpack the state of the workforce five years after the peak of COVID-19. Later, Rae brings on Optum Advisory workforce management experts Sherilynn Quist and Anne Schmidt to break down their work in the field, addressing what they call the “blocking and tackling” of workforce efficiency within a hospital. Links: Optum Advisory: Healthcare consulting services [Webinar, May 18] Broaden your definition of the nursing care team Insights from Advisory Board's 2024 workforce benchmarks [Roundtable, Aug. 18-19] How to thrive in an evolving nursing landscape Ep. 205: Live from ViVE 2024: Four leaders on how technology is redefining clinical work Ep. 207: Nurses Week 2024: Build care teams, not assembly lines 2025 Advisory Board Summit - Carlsbad, CA Advisory Board Fellowship Advisory Board is a subsidiary of Optum. All Advisory Board research, expert perspectives, and recommendations remain independent. A transcript of this episode as well as more information and resources can be found on RadioAdvisory.advisory.com.
In the first two months of the Trump administration, the political and regulatory environment have shifted considerably. Since the inauguration, we’ve fielded dozens of questions about the slew of executive orders, cuts to research funding, HHS layoffs, tariffs, and an unstable economic outlook. All of that is coupled with the potential for major payment cuts to government-funded healthcare and rising scrutiny over public health and the healthcare industry writ large. The sheer pace of change leaves many healthcare leaders wondering where they need to focus their attention and energy. This week, we’re here to clarify some of the chaos and help leaders focus their efforts on what is most pressing and most actionable. To do that, host Rachel (Rae) Woods invites Advisory Board experts Natalie Trebes and Max Hakanson to break down the operating conditions as the second Trump term takes shape. We’re here to help: If there are specific policy areas or issues that you want to hear more about, or you are interested in talking to our research team (or getting access to our working documents), let us know by leaving us a voice message or emailing us. Links: Ep. 230: Elections results are in: What healthcare leaders need to know How could Trump’s new tariffs impact healthcare? Thousands laid off at HHS: What you need to know RFK Jr. wants to change how Medicare pays doctors Health policy roundup: The latest on measles, abortion, and gender-affirming care Health policy roundup: Trump signs executive order on price transparency Learn more about the origins of Ozempic Learn more about the Advisory Board Summit in Carlsbad, CA. A transcript of this episode as well as more information and resources can be found on RadioAdvisory.advisory.com.
There is a lot happening in federal policy that may affect healthcare payment transformation and care delivery. But we’ve said it before: healthcare leaders can’t afford to focus on fighting near-term fires at the expense of driving long-term success and sustainability. Amidst the uncertainty, it’s more important than ever to push forward conversations about how we can structurally evolve our systems to align incentives to patient health. So, in this episode, we’re talking about value-based care. Host Abby Burns invites Advisory Board expert Clare Wirth and Optum Advisory expert Erik Johnson to unpack the state of VBC in early 2025, and where they see it going next. They debate whether bundles can truly be considered “value-based care,” how specialty care will fit into the future VBC landscape, and which payer lines of business they have their eyes on. Links: VBC in 2025: What's now and what's next Inside Advocate Health’s VBC approach that saved $136M How UNC Health made VBC sustainable in an academic health system The obstacles between health systems and VBC success Ep. 201: Value series: What does health system VBC adoption actually look like? Ep. 231: Big deal, little deal, or no deal? A 2024 health policy retrospective Value-based care landing page Enjoying this episode? Discover how Optum Advisory experts can help you design a VBC strategy to drive sustainable growth and profitability for your organization. Connect with one of our experts today. Advisory Board is a subsidiary of Optum. All Advisory Board research, expert perspectives, and recommendations remain independent. A transcript of this episode as well as more information and resources can be found on RadioAdvisory.advisory.com.
Partnerships between health systems and life sciences play a critical role in giving patients access to the best data, therapies, and technologies available in the market. However, these partnerships can be less fulfilling if both sides don’t align on purpose and expectations. This week, host Rachel (Rae) Woods invites Advisory Board expert Fanta Cherif to break down the current state of health system and life sciences partnerships, share the spectrum of collaboration options, and the strategic middle ground that is often overlooked, but can serve as a lifeline in today’s challenging economic landscape. Let us know what you think about today’s discussion, or share your ideas for future episode topics by leaving us a voice message or emailing us. Links: Ep. 151: Making vendor-provider partnerships work Ep. 183: John Muir Health and Optum reflect on what makes their partnership work How to bridge the communication gap in vendor-provider partnerships Metrics that matter: How different stakeholders define value in healthcare Join Advisory Board experts for these upcoming philanthropy webinars: March 20, 2025 (1-2 p.m. ET/10-11 a.m. PT): What the future of health system growth means for philanthropy leaders Register here: What the future of health system growth means for philanthropy leaders April 1, 2025 (1-2 p.m. ET/10-11 a.m. PT): How market data can transform your philanthropy strategy Register here: Using market data to inform your philanthropy strategy A transcript of this episode as well as more information and resources can be found on RadioAdvisory.advisory.com.
On September 27, 2024, Ballad Health was forced to evacuate Unicoi Hospital in rural Tennessee due to a freak flash flood caused by Hurricane Helene. After two failed rescue attempts, an aerial operation managed to successfully airlift all 70 people who were trapped on the rooftop of the small community hospital. In an era where extreme climate events are increasingly common, more healthcare leaders are being forced to reckon with the reality of leading through natural disasters. This week, Lisa Carter, President of Ballad Health’s Southern Region, joins Radio Advisory to recount the events of that day, reflect on how they tested her leadership, and underscore why we can’t rely on our “old normal” when it comes to disaster preparedness. Links: Homepage | Ballad Health Healthcare and climate change: Why sustainability is a strategic imperative Ep. 219: The business case for going green Ep. 164: Boston Medical Center's path to sustainability (and how they're funding it) Ep. 161: Unwavering purpose, the creation of Ballad Health 3 ways to engage and motivate your team in uncertain times Learn how the Advisory Board Fellowship can equip leaders to lead in an increasingly volatile, uncertain, complex, and ambiguous world. In this episode we featured audio clips from CBS News, ABC News, and NPR. You can find the full segments here: New wildfires erupt in Southern California Historic winter storm across the Deep South - YouTube Hospitals face months of IV fluid shortages after Helene damages N.C. factory : NPR A transcript of this episode as well as more information and resources can be found on RadioAdvisory.advisory.com.
We’ve said it before on Radio Advisory: hospital volumes are back. But leaders know this isn’t necessarily a sigh of relief. With a lot of hospitals at—or even over—capacity, hospital leaders need to find ways to improve patient throughput and reduce length of stay. And trust me, they’ve been trying. The question is, why is it so hard to address capacity and length of stay, and what can leaders do about it in 2025? This week, host Rachel (Rae) Woods is joined by Advisory Board expert Isis Monteiro. Isis shares what she learned from her “world tour” of talking with 45 healthcare leaders from nine countries to understand how they’re tackling capacity challenges. Throughout the conversation, they break down three root causes of high hospital length of stay and highlight examples of how organizations are overcoming them. Links: Ep. 225: Patients are back – so why aren't hospital margins? Ep. 221: How will health system growth look different in 2025 and beyond? Provider operations Interested in learning more about our length-of-stay reduction research? Join us live at an Advisory Board Summit and attend a dedicated session on how your organization can address foundational capacity, throughput, and length-of-stay challenges. Check out Advisory Board’s Hospital Benchmark Generator tool to see how your hospital’s length-of-stay stacks up and pinpoint improvement opportunities for improvement to remain competitive. Insights from the 2026 CMS Advance Notice A transcript of this episode as well as more information and resources can be found on RadioAdvisory.advisory.com.
The cost and quality of care can vary dramatically—even within the same health system. This has real ramifications for patients and clinicians, not to mention system outcomes. But reducing unwarranted variation in clinical care is much easier said than done. In 2019, UNC Health launched a care redesign office to take on the job. They identified 24 sources of variation to target. And their efforts were so successful that five years later, it was time to set their sights on a new list of targets—this time with a partner. In this episode, host Abby Burns invites Cyndi Hall, former Executive Director of Care Redesign at UNC Health, and Dr. Larry Marks, Executive Medical Director for Care Redesign, Professor of Radiation Oncology, and Assistant Dean of Organizational Health and Quality at UNC Health and School of Medicine, to break down the last five years of their care design work. They share how they selected which clinical areas to target, stories of what it means when this work is successful, and through it all, underscore the role of true change agents of this work: the clinicians themselves. Note: Cyndi Hall is now Senior Advisor for Healthcare Plus Solutions Group where she is translating her expertise in care variation reduction to help provider organizations improve the clinician onboarding process. Reducing clinical variation is something Advisory Board is actively researching in 2025. If CVR has been on your organization’s docket and you have best practices to share, reach out to us at podcasts@advisory.com with the subject line “Sharing our CVR work” to get in touch with our research team. Links: 4 common pitfalls in care standardization — and how to overcome them Care variation reduction metric picklist UNC Health | Changing Lives for the Better Healthcare Leadership Training & Consulting | Healthcare Plus Solutions Obtaining Imaging Cost and Quality Information in Femoroacetabular Impingement: The Patient Experience - PMC Insights from the 2026 CMS Advance Notice How Steindler Orthopedic improved joint replacements with digital surgical technologies A transcript of this episode as well as more information and resources can be found on RadioAdvisory.advisory.com.
As hospitals face mounting financial pressure in 2025, health systems are reckoning with the fragility of their legacy business models. Ambulatory networks have long been considered an opportunity for growth, but legacy thinking still focuses on how ambulatory sites could drive inpatient volumes. That strategy is no longer working (and perhaps, never did). Savvy health leaders are now asking, how should we be evolving our ambulatory strategy in 2025, and setting ourselves up for 2035? To answer those questions, host Rachel (Rae) Woods invites Advisory Board experts Jordan Peterson and Nick Hula to break down why the ambulatory strategy used for the last decade is no longer enough, why ambulatory growth needs to be top of mind for health system strategists 2025, and how leaders can shift their efforts from ambulatory sites to ambulatory capabilities. Links: Ep. 236: What CEOs need to know in 2025 (Part 2) The role of ASCs in health system growth strategy It’s time for systems to change how they prioritize and design their ambulatory strategy 4 considerations for creating successful ASC strategies Optum Advisory: Healthcare consulting services A transcript of this episode as well as more information and resources can be found on RadioAdvisory.advisory.com.
Back in December, we discussed why leaders should re-envision their approach to digital change management. But to truly implement digital change, health systems must understand their organization’s success (or failure) to date. However, assessing digital progress is not a simple task. While models exist that measure digital maturity in other industries, there is a serious lack of tools to measure progress in the healthcare field—which is why we made our own. This week, host Rachel (Rae) Woods invites John League, Advisory Board digital health expert, and K. R. Prabha, Optum’s Vice President of Strategy, Growth and Innovation to define what digital maturity for health systems looks like and unpack why so many organizations are stalled at merely “being” digital. Together, they introduce a new tool they’ve designed to help health systems assess their own digital maturity. For an on-the-ground perspective, Rae invites Dr. David Ingham, Vice President and Chief Information Officer of Allina Health, to discuss how Allina Health leveraged this tool to assess their progress and prioritize next steps on their digital journey. Links: Understand the digital maturity of your health system Ep. 233: Your digital strategy needs more than “change management” Connect with Optum Advisory to design your digital transformation strategy Allina Health Care & Medical Services In MN & Western WI Get in touch with us [Webinar, 2/19] Imaging market trends in 2025 Advisory Board is a subsidiary of Optum. All Advisory Board research, expert perspectives, and recommendations remain independent. A transcript of this episode as well as more information and resources can be found on RadioAdvisory.advisory.com.
Advisory Board experts Natalie Trebes and Max Hakanson rejoin host Abby Burns for part two of our conversation digging into the trends and challenges healthcare leaders need to pay attention to in 2025. Last week, our experts covered evolving power dynamics around network design, drug cost/spend, and cyber threats. This week, the group shifts their attention to unpack what’s happening with our core care delivery infrastructure. What is the state of health systems—and what’s in store for them? They also tackle the elephant in the room: how should leaders be thinking about the policy landscape as we enter a new administration? Our State of the Industry research team is kicking off their annual research and wants to hear from you to help shape the research! We want to know what your “up at night” issues are, what questions you have, and what your organization is focusing on in order to navigate the waters ahead. Get in touch with the team by emailing podcasts@advisory.com. This episode was recorded on Jan. 8th, 2025. Links: 17 things CEOs need to know in 2025 Ep. 235: What CEOs need to know in 2025 (Part 1) Ep. 231: Big deal, little deal, or no deal? A 2024 health policy retrospective The state of the industry: What healthcare leaders need to know for 2025 [Webinar, 3/11] Insights from the 2026 CMS Advance Notice Aortic stenosis is vastly undertreated: Know how to identify and address it A transcript of this episode as well as more information and resources can be found on RadioAdvisory.advisory.com.
While the new year often feels like a time to reset and regroup, 2025 has started off in a sprint. As pressures continue to grow across all sectors of the industry, it’s no secret that leaders need to think and act differently in order to succeed in the new year. With so many swirling changes, it can be hard to sort through the most important topics, trends, and perspectives to focus on. That’s where Advisory Board—and Radio Advisory—come in. This week’s conversation is the first of a two-part series that digs into what healthcare leaders need to have on their radar in 2025. Host Abby Burns invites Advisory Board experts Natalie Trebes and Max Hakanson to break down what Medicare Advantage breakups, untenable drug costs, and evolving cyber threats signal about changing power dynamics across the healthcare industry. Stay tuned for part 2 of the conversation next week, where we’ll cover the state of health systems and, of course, what we expect to see in the policy landscape this year. This episode was recorded on Jan. 8th, 2025. Links: 17 things CEOs need to know in 2025 The state of the industry: What healthcare leaders need to know for 2025 The data health system vendors need to know in 2025 4 strategic pivots for 2025 (and beyond) Cybersecurity in healthcare Ep. 227: The changing tide of Medicare Advantage State of the healthcare industry A transcript of this episode as well as more information and resources can be found on RadioAdvisory.Advisory.com.
2024 was filled with upswings and downswings in the healthcare industry. Whether it was unprecedented cyberattacks, the continued rise of GLP-1 therapies, or the return of hospital volumes, healthcare leaders stayed busy. And things aren’t expected to slow down in 2025. To give you a preview of where we may be headed, this week, hosts Rachel (Rae) Woods and Abby Burns invite five Advisory Board experts to break down what their teams will be researching in 2025 and why these topics matter for health leaders. Throughout the episode, our experts preview how health system service lines, value-based care, care variation reduction, artificial intelligence, and specialty pharmacy will change in 2025 and beyond. Links: The state of the industry: What healthcare leaders need to know for 2025 Get early access to our 2025 executive briefing Service lines and specialty care landing page Value-based care landing page Artificial intelligence landing page Hospital and health system trends landing page 4 common pitfalls in care standardization — and how to overcome them Learn more about Advisory Board Fellowship A transcript of this episode as well as more information and resources can be found on www.advisory.com/RadioAdvisory.
A top podcast for healthcare leaders, with over one million downloads, Radio Advisory is your weekly download on how to untangle the industry's most pressing challenges to help leaders like you make the best business decisions for your organization. From unpacking major trends in care delivery—like site-of-care shifts and the rise of high-cost drugs—to demystifying stakeholder dynamics, to shining a spotlight on priorities that may get overlooked, we're here to help. Our hosts and seasoned researchers talk with industry experts to equip you with knowledge to confront today's unanswered questions in healthcare. New episodes drop every Tuesday.
The healthcare industry talks a lot about “change management,” the idea that through careful stewardship, the process of change can be made a little bit easier. The problem is, it’s a lot easier to talk about change than it is to manage it well. This is especially difficult when it comes to digital transformation, a space that is evolving almost too fast to keep up with. So how should leaders be thinking about navigating change in such a complex environment? To answer that question, in the first episode of a two-part series on managing digital change, host Rachel (Rae) Woods invites Advisory Board digital health expert John League, and later, Optum Advisory Vice President of Digital Transformation, Matt Matousek, to break down why the industry might need to shy away from the term “change management”, what it means to manage change well, and give on-the-ground examples of organizations who have had success with digital transformation. Links: John’s LinkedIn post Connect with Optum Advisory to design your digital transformation strategy Ep. 214: Is Governance the answer to AI integration? Duke says yes. 4 key issues that will shape the future of digital health The state of the industry: What healthcare leaders need to know for 2025 Get exclusive, early access to Advisory Board’s annual “What CEOs need to know” briefing. Advisory Board is a subsidiary of Optum. All Advisory Board research, expert perspectives, and recommendations remain independent. A transcript of this episode as well as more information and resources can be found on www.advisory.com/RadioAdvisory.
Employers have been saying for years that they can’t absorb any more cost growth for health insurance; health plans feel like they’ve squeezed about as much juice as possible out of traditional cost mitigation levers. Both are looking for creative alternatives to curb rising health costs. Enter ICHRAs. Usually, when we talk about the health insurance landscape, we focus on Medicare, Medicaid, or employer-sponsored insurance. But roughly 21 million people in the US are covered by individual marketplace plans, and in 2020, a new type of plan hit the individual market, moving health insurance from a “defined benefit” to a “defined contribution” in an effort to curb employer health costs. In this episode, host Abby Burns invites Advisory Board health plan expert Morghen Philippi to shed light on what Individual Coverage Health Reimbursement Arrangements, or ICHRAs, actually are, how employers, plans, and providers are responding to their rise, and what leaders need to keep an eye on when it comes to these plans. Note: This episode was recorded prior to the 2024 elections. Given the results, it is unlikely that the enhanced subsidies referenced in this episode will be renewed, which will affect the health of the individual marketplace. If enhanced subsidies expire at the end of 2025, you can expect it to have a direct impact on the individual market and on ICHRA viability, specifically. That said, because of the first Trump administration’s role in establishing the ICHRA model, the incoming administration may work to support ICHRA growth. Links: Is the cost of employer-sponsored insurance at a tipping point? Market outlook for individual and small group health insurance Ep. 176: Test, fail, and test again: Morgan Health's approach to employer costs Enhanced subsidies propelled ACA marketplace enrollment. What’s next? What health system growth will look like in 2025 Get exclusive, early access to Advisory Board’s annual “What CEOs need to know” briefing. A transcript of this episode as well as more information and resources can be found on www.advisory.com/RadioAdvisory.
Last week on Radio Advisory, we broke down what healthcare leaders need to know for 2025 and beyond following the recent elections. But before we move on from 2024 completely, we have to acknowledge that there’s been a lot moving in the policy space this year, and frankly, there have probably been a few important policy areas on your radar that we haven’t discussed. That’s why this week, host Abby Burns invites Advisory Board experts Gina Lohr, Sarah Roller, and Paul Trigonoplos to dive into three major policy areas of the last year: Medicare drug negotiations, changes to physician employment and payment, and an emerging mandatory bundled payment model called TEAM. The experts unpack how these policies are affecting the industry, how the elections outcomes may impact them, and, critically, how much attention leaders should be paying them going forward. In other words, should leaders consider each policy a big deal, a little deal, or no deal? Links: Ep. 230: Elections results are in: What healthcare leaders need to know State-level healthcare ballot measures that passed (and failed) CMS’ TEAM payment model is here. How should hospitals prepare? Transforming Episode Accountability Model (TEAM) Your guide to CMS' 14 value-based payment models Medicare announces 10 new drug prices following negotiations A federal judge just blocked FTC's noncompete ban The Hospital Benchmark Generator Market Scenario Planner (Correction: An earlier version of this episode misstated that there is a $200 out-of-pocket cap on drug spending going into place. That number is $2,000 and references the Medicare Part D out-of-pocket cap set to begin in 2025. We have removed the number from the audio.) Get exclusive, early access to Advisory Board’s annual “What CEOs need to know” briefing. 2 ways labs can embrace innovation to drive revenue and accelerate growth Market Scenario Planner A transcript of this episode as well as more information and resources can be found on www.advisory.com/RadioAdvisory.
(Note: This episode was recorded on November 7, 2024) The results of the 2024 elections are in: Donald Trump will be the 47th President of the United States, and we are all but certain to have a Republican trifecta at the federal level. Admittedly, there’s a lot we don’t know about what healthcare will look like under a second Trump administration—a lot will depend on who is appointed to key leadership positions overseeing federal health agencies and Congressional committees. But while we wait for those appointments, what can we anticipate based on President-elect Trump’s first term, campaign, and the Republican platform? This week, hosts Rachel (Rae) Woods and Abby Burns invite Advisory Board experts Natalie Trebes and Ben Palmer to break down the implications of a second Trump term on the healthcare industry. They unpack how power dynamics have shifted since the first administration, and what we’re likely to see on issues like the ACA, enhanced subsidies, Medicaid, drug pricing, abortion, and more. Links: What the 2024 elections mean for healthcare The election is over. Here's how to talk to your team today. Ep. 206: 24th Secretary of HHS Alex Azar shares his vision on healthcare transformation State-level healthcare ballot measures that passed (and failed) Why healthcare leaders should look to their state elections more than the national race Join 165,000+ healthcare leaders and get the industry’s most important news in your inbox—every day. A transcript of this episode as well as more information and resources can be found on www.advisory.com/RadioAdvisory.
Conversations around GLP-1s in today’s healthcare market are mixed. Some stakeholders are thrilled with their potential, while others are filled with questions and even anxiety about how these powerful and popular drugs will impact their business. Many in the industry have been asking for months: “What can GLP-1s do?” But maybe this is the wrong question. Leaders should be asking “What CAN’T GLP-1s do?” To answer that question, live from HLTH 2024, host Rachel (Rae) Wood invites Rob MacNaughton, CEO of lifestyle intervention and obesity management organization Calibrate, Rita Glaze-Rowe, President at life sciences research organization Real Chemistry, and Dr. Spencer Nadolsky, lipid and obesity specialist and founder to break down the cross-industry perspective on GLP-1s and how the healthcare leaders should be thinking about both the potential and limitations of these novel therapies. In a market that is buzzing around the novel medications, these experts suggest a new focus on comprehensive weight management programs. Links: Treating Obesity At Scale: Real-World Outcomes Using Medication And Intensive Lifestyle Intervention | Calibrate Real Chemistry - AI and Ideas Transforming Healthcare Ep. 222: It's not just GLP-1s; here's what comprehensive weight management looks like Ep. 159: Ozempic, Wegovy, and our questions on weight management drugs How 3 health systems provide comprehensive care for obesity 4 key elements of comprehensive obesity care (and how they look in practice) Join 165,000+ healthcare leaders and get the industry’s most important news in your inbox—every day. What the 2024 elections mean for healthcare [Webinar, 10/24] How the 2024 elections could impact the healthcare industry A transcript of this episode as well as more information and resources can be found on www.advisory.com/RadioAdvisory.
Remote patient monitoring (RPM) has a surprisingly long history in healthcare. As technology improves, RPM can expand physician capacity, better manage complex patients, and improve total cost of care. Despite RPM’s potential, leaders often struggle to root RPM in a clear business case, or they underinvest in implementation, never fully integrating RPM into existing workflows and systems. This week, host Rachel (Rae) Woods invites Advisory Board RPM expert Lauren Woodrow and Advisory Board cardiovascular expert Kristin Strubel to break down why RPM technologies aren’t being properly utilized, guide leaders on where to place their strategic bets, and share use cases for how RPM can improve quality and finances across service lines. Links: How 4 specialty service lines are embracing remote patient monitoring The rise of remote patient monitoring: Ensuring accessibility 3 strategies to unlock the potential of remote patient monitoring How Frederick Health saved $2.3M through remote patient monitoring What the 2024 elections mean for healthcare Mapped: Key healthcare-related ballot measures to watch A transcript of this episode as well as more information and resources can be found on www.advisory.com/RadioAdvisory.
For years, the best word to describe Medicare Advantage (MA) was “untouchable.” Hugely popular among seniors, profitable for health plans—the hybrid public-private payment model grew to the point that it now covers more seniors than traditional Medicare. But in the past few years, the tide has started to change. And if you’ve been paying attention in recent months, you’ll have seen headlines announcing that payers that are scaling back their MA offerings and providers are exiting MA contracts. The MA market has gone from “untouchable” to “volatile.” The question is: why is this happening, and what does it mean for payers, providers, and seniors moving forward? In this episode, hosts Rachel (Rae) Woods and Abby Burns invite health plan experts Max Hakanson and Chelsea Needham to dissect what is going on in MA and how plans and providers are—or should be—navigating the changing tide. Links: Ep. 203: Value series: Is the future of VBC in specialty care? Zing Health & Strive Health say yes. Ep. 149: Senior Care (Part 1): Specialized primary care for an aging population Ep. 150: Senior Care (Part 2): The rapid growth of Medicare Advantage 3 traits health plans want in a provider partner 4 traits providers want in a health plan partner Around the nation: CMS releases Medicare Advantage Star Ratings [Webinar, 10/24] How the 2024 elections could impact the healthcare industry A transcript of this episode as well as more information and resources can be found on www.advisory.com/RadioAdvisory.
As care delivery becomes more complex and new disruptors join the scene, one thing has become clear: operational excellence is now table stakes in ensuring your organization’s financial sustainability and winning patients. In this episode, recorded live from Advisory Board’s 2024 Strategy Summit, guest host and Managing Director of Physician and Medical Group Research at Advisory Board, Sarah Roller, invites Dr. Mary Jo Cagle, CEO of Cone Health and Dr. Cynthia Horner, Chief Medical Officer of Amwell and President of Amwell Medical Group, to unpack what it takes to achieve operational excellence, why adaptive leadership is essential to success, and why true operational excellence does not have to be as daunting as it seems. Links: Cone Health | We're Right Here With You Hybrid Care at Scale | Amwell 8 lessons for facility planners from our recent strategy summit Pivots for a sustainable future Provider operations Pivots for a Sustainable Future Virtual Summit Join 165,000+ healthcare leaders and get the industry’s most important news in your inbox—every day. A transcript of this episode as well as more information and resources can be found on www.advisory.com/RadioAdvisory.
For years, health systems have been holding their breath to see if patient volumes would finally return to pre-pandemic levels. Because—per conventional wisdom--if volumes return, then so will operating margins. Right? Not so fast. In this episode, host Abby Burns invites Advisory Board experts Sebastian Beckmann and Elizabeth Orr to explore why with the positive volume forecast we see in our projections won’t automatically translate to a healthy financial outlook. Later, Optum Advisory expert Alex Kist joins the group to share what it’s looked like to help one health system put their local data into action to achieve the kind of differentiated growth our experts have been touting. Links: Market Scenario Planner 3 ways Boulder Community Health became a provider of choice for CV care Revolutionizing cardiology at Boulder Community Health Ep. 221: How will health system growth look different in 2025 and beyond? Healthcare Consulting Services | Optum Advisory Advisory Board's 7 key factors for future volume growth Charted: The financial gap between rich and poor hospitals grows If you are looking for hands-on support, email us at podcasts@advisory.com or learn more about how Advisory Board can help. Join 165,000+ healthcare leaders and get the industry’s most important news in your inbox—every day. Strategic Planner's survey 2024 Survey insights: 6 priorities for health system strategists in 2024 Advisory Board is a subsidiary of Optum. All Advisory Board research, expert perspectives, and recommendations remain independent. A transcript of this episode as well as more information and resources can be found on www.advisory.com/RadioAdvisory.
Two weeks ago on Radio Advisory, we told our listeners that the number one area of focus for health system growth is operational excellence, and a major part of that is capturing all of the revenue on the table from your medical group. Healthcare organizations have spent the last decade buying up medical groups and physicians, in part because of the “promise” of downstream referrals. It is a long-held belief that physician employment leads to higher referral integrity. But according to an Advisory Board data analysis, that doesn’t hold true - just 55% of total referral revenue attributed to employed PCPs is realized in-network. This week, host Rachel (Rae) Woods invites Advisory Board physician experts Eliza Dailey and Colleen Wagner to unpack where referral leakage actually happens and share the real (and relatively easy) steps organizations can take to reduce referral leakage. Links: Tools to reduce referral leakage in the medical group Are employed PCPs more likely to refer within their health systems? Ep. 221: How will health system growth look different in 2025 and beyond? Medical group integration 3 shifts impacting medical groups: 2024 update on the physician landscape Strategic Planner's survey 2024 Survey insights: 6 priorities for health system strategists in 2024 Digital surgery: A way for orthopaedic programs to set themselves apart A transcript of this episode as well as more information and resources can be found on www.advisory.com/RadioAdvisory.
In the midst of the COVID-19 pandemic, The Centers for Medicare & Medicaid services released the Acute Hospital Care at Home payment waiver. The action was expected to usher in a new era of home-based care. But while it’s certainly grown in recent years, frankly, that massive shift hasn’t happened. The question is, why? This week, host Abby Burns invites Dr. Matthew Richards, Senior Medical Director of home-care enablement company Medically Home, to explore the role that home-base care could play in the future of healthcare, and to unpack the misconceptions that prevent home-based care from playing a larger role in the healthcare ecosystem today. Links: Home - Medically Home 5 trends (re)shaping site-of-care shifts The future of the acute care at home model Ep. 64: Why Contessa's CEO believes hospital at home benefits everyone (including hospitals) Strategic Planner's survey 2024 Survey insights: 6 priorities for health system strategists in 2024 A transcript of this episode as well as more information and resources can be found on www.advisory.com/RadioAdvisory.
(This episode originally aired on September 26, 2023.) Value-based care has been dominating industry conversations in recent years. Here on Radio Advisory, we talk a lot about best practices, how to make the right investments, and how to best prepare leaders for the future of value-based care. But given all this momentum, we want to spend time asking the question: what are the misconceptions or misaligned expectations that leaders have around value-based care? In this episode, host Rachel (Rae) Woods invites Advisory Board value-based care expert Daniel Kuzmanovich and Optum Advisory Service's SVP of value-based care, Erik Johnson, to discuss the mindset shifts they think leaders should be making when pursuing a sustainable value-based care strategy. Throughout the conversation they discuss what leaders are currently getting wrong, how myths about value-based care are impacting the industry, and more. Links: Our Value-based Care playlist Ep. 172: Build a value-based enterprise: Live from 2023 Value-Based Care Summit Ep. 126: [Bonus content] Commercial risk is possible—here's how How Health Plans Can Support Providers in Risk The climb to value-based care 3 strategies for a successful sleep apnea therapy program: Lessons from ENTTX's ASC partnership Strategic Planner's survey 2024 Survey insights: 6 priorities for health system strategists in 2024 Advisory Board is a subsidiary of Optum. All Advisory Board research, expert perspectives, and recommendations remain independent.
In the last few years, all eyes have turned to GLP-1s as an industry-altering answer to obesity treatment and weight management. But the fact is, these drugs can’t – and shouldn’t – work in a vacuum. There is a fear that attention on GLP-1s may even blind leaders to the other services that go into providing effective obesity care. So, what should leaders be thinking about when designing and and delivering effective obesity care? To answer that question, host Abby Burns invites Advisory Board experts Chloe Bakst, Payton Grimes, and Atticus Raasch to unpack what comprehensive weight management programs look like in practice, and why—if done well— they can benefit patients, clinicians, and health systems. Links: 4 key elements of comprehensive obesity care (and how they look in practice) How 3 health systems provide comprehensive care for obesity Ep. 181: Does healthcare's approach to obesity harm patients? Ep. 159: Ozempic, Wegovy, and our questions on weight management drugs Learn more about On-demand Courses A transcript of this episode as well as more information and resources can be found on www.advisory.com/RadioAdvisory.
When we talk about “health systems,” it can sound like we’re talking about a monolith. But in reality, the $1.4 trillion dollar health system sector is made up of a diverse range of players. Academics and safety nets; urban and rural systems; 1,000-bed systems and 25-bed critical access hospitals. The question is, especially as systems emerge from the financial hardships of the past few years, how do those differences translate to the ways systems are running at growth? In this episode, the third and final installment in our series leading up to Advisory Board’s Strategy Summit, host Abby Burns invites Advisory Board health system experts Elizabeth Orr and Marisa Nives to unpack how leaders across the health system sector are thinking differently about growing in 2025 and beyond. Links: Hospitals' top strategic priorities — and what they mean for development leaders Ep. 220: Why AI in healthcare is more than just ChatGPT Ep. 219: The business case for going green Ep. 218: [Encore + bonus content] Site-of-care shifts: It's time to go on offense Charted: The financial gap between rich and poor hospitals grows Join us at the Pivots for a Sustainable Future Summit on September 10-11, 2024. Learn about Advisory Board Fellowship A transcript of this episode as well as more information and resources can be found on www.advisory.com/RadioAdvisory.
We’ve talked a lot about AI on Radio Advisory, with a particular emphasis on generative models and their capabilities. But are there other models of AI that are flying under the radar? Today’s episode focuses on computer vision and its potential to shift how we think about the use of technology in healthcare. For the second episode in our series leading up to Advisory Board’s upcoming Strategy Summit, host Abby Burns invites digital health experts Ty Aderhold and Elysia Culver to break down why computer vision should be on our minds, arguably just as much as generative AI. Links: Ep. 185: AI adoption: why you can't afford to "wait and see" 10 ways computer vision can transform the future of healthcare Computer vision in healthcare Join us at the Pivots for a Sustainable Future Summit on September 10-11, 2024. Register for the How to harness the potential of digital experience in healthcare webinar on September 17. Learn more about Advisory Board Sponsorship. A transcript of this episode as well as more information and resources can be found on www.advisory.com/RadioAdvisory.
It's no secret that climate change has had a massive effect on population health, but it’s also impacting healthcare business. Did you know that energy costs have gone up by 28% in the past five years? Health systems in particular can shave percentage points off their annual costs by reducing their energy consumption—but there is both a knowledge gap and an action gap keeping leaders from taking advantage of the opportunity. Advisory Board’s Strategy Summit on September 10-11 is all about the pivots health systems need to make for a sustainable future – no better way to kick off our lead-up to the event than by taking that quite literally and talking about environmental sustainability. In this episode, host Abby Burns invites Advisory Board expert Miles Cottier to break down how and why health business leaders need to prioritize environmental sustainability. They explore the financial case for moving to renewable energy sources, how regulatory pressures may (or may not) shape the future of environmental action, and what leaders can do today to support their green initiatives. Links: Green financing for health systems Climate change is affecting heart health. Here’s what you can do. Ep. 119: How health leaders can address climate change Ep. 164: Boston Medical Center's path to sustainability (and how they're funding it) Join us at the Pivots for a Sustainable Future Summit on September 10-11, 2024 A transcript of this episode as well as more information and resources can be found on www.advisory.com/RadioAdvisory.
This week, host Abby Burns invites Advisory Board expert Sebastian Beckmann back to Radio Advisory to provide an update—as promised—on what his team has uncovered about site-of-care shifts in the six months since he first brought this research to the pod. Hint: there’s about $50B at play. This episode is a modified encore of Episode 195: Site-of-care shifts: It’s time to go on offense.” In that episode, Sebastian and fellow Advisory Board expert Nick Hula joined Abby to break down how health systems should be thinking about site-of-care shifts as a part of their growth strategies, including making the transition from a “defensive” mindset to prevent volume shifts, to an “offensive” mindset to capture them. The original episode will play almost in its entirety, with interjections from Abby and Sebastian to dig deeper into what the site-of-care shift opportunity—or risk—actually looks like across markets and services. Links: Seize the $50 billion site-of-care shift opportunity Interactive maps: See where site-of-care shifts are having the biggest impact Site-of-care shifts: Healthcare’s $50B opportunity Your guides to volume growth in 6 key service lines 4 takeaways from our updated provider volume forecast 5 trends (re)shaping site-of-care shifts What’s happening with joint replacement volumes? Ep. 193: Is health system growth still possible? Learn more about On-demand Courses Use the Market Scenario Planner A transcript of this episode as well as more information and resources can be found on www.advisory.com/RadioAdvisory.
(This episode originally aired on September 12, 2023.) With rising costs and tightening margins, the industry is continually looking for ways to "bend the cost curve" while maintaining, or even increasing, quality and performance. One stakeholder in particular, employers, are feeling significant pressures from inflation, hospital consolidation, the rise of high-cost drugs, and more. While many legacy cost-saving strategies have focused on reducing employer costs, it may be time to shift focus to lowering costs for employees as well. In this episode, host Rachel (Rae) Woods invites Advisory Board payer expert Max Hakanson and Innovation lead at JPMorgan's Morgan Health Rivka Friedman to discuss what employers can do to rein in healthcare costs, both for themselves and their employees. Throughout the discussion, they discuss why legacy cost-sharing strategies may be insufficient, and what new innovations are showing promise in the market. Links: Home | Morgan Health Ep. 165: Employer series: Is the cost of employer-sponsored insurance unsustainable? Investigating the high costs in employer-sponsored insurance 5 health benefits strategies for self-funded employers 3 things to know about ESI (that you won't find in a benefits survey) Learn more about Advisory Board Sponsorship
(This episode originally aired on March 12, 2024.) The relationship between health plans and providers has always included an element of friction, but lately, it seems like the temperature is rising. And you've probably noticed – public contracting disputes increased by 69% between 2022 and 2023. That's why, in this episode, host Abby Burns invites Advisory Board experts Max Hakanson and Eileen Fennell to discuss why the state of affairs seems to be getting worse, how key flashpoints are fanning the flames, and what each stakeholder says they need to see from their partners in order to mend the relationship. Plus, Advisory Board digital health expert Ty Aderhold makes a cameo appearance to help answer the question: Is AI the solution here? Links: 7 things we want to fix in 2024 (and how to get there) A new era of payer-provider relationships The new era of provider enablement AI in healthcare: Insights from 10 C-suite executives Learn about the Advisory Board Fellowship
Healthcare leaders have dozens of priorities on their plates, and achieving innovation is not as simple as just buying a new technology or implementing a new care model. Frankly, it can be overwhelming not just to see innovations through, but even to get started. So, what does it really take to innovate? And how do you align your organization’s challenges with the solutions or innovations that are being presented to you? In this special episode, live from Advisory Board’s 2024 Clinical Innovation Summit, guest host and Advisory Board digital health expert John League invites Dr. Ayo Ajaiyeoba from Blue Cross Blue Shield of Kansas City, and Elliot Green, cofounder and CEO of Dandelion Health, to dive deep on the realities of innovation. Throughout the discussion, they explore what it takes to get started, how to act in the face of ambiguity, and how you should be thinking about tools like data and partnerships to achieve your goals. Links: Blue Cross Blue Shield Dandelion Health Top 5 takeaways from our Clinical Innovation Summit 4 imperatives for the future of healthcare innovation Truly personalized care is possible. Here's how to make it a reality. More upcoming events from Advisory Board Learn more about Advisory Board On-Demand Courses A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.
It seems like a no-brainer for healthcare organizations to allocate time and attention to a health condition that is guaranteed to affect 50% of adults during their midlife years—but that hasn’t been the case. We’re seeing momentum around making menopause mainstream—from the White House directing research funding, to Hollywood stars talking openly about menopause, to the rise of femtech companies geared toward helping consumers navigate the clinical and social effects of menopause. But though 100% of women in midlife will experience this clinical event, the reality is that most women’s health programs are primarily focused on what our guests have referred to in the past as the “bikini approach” to women’s health, and have largely ignored the needs of women in the post-reproductive years. From a clinical and financial standpoint, this is a missed opportunity. And given 80% of the healthcare workforce is women, and one-third of those women are in midlife, it’s also a competitive vulnerability. That’s why this week, host Rachel (Rae) Woods invites Advisory Board women’s health experts Kara Marlatt and Gaby Marmolejos to explore how provider and employer leaders can build systems that account for and address women’s health needs “beyond the bikini.” Links: 5 ways employers can support women's health during midlife Five women leaders on the shifting landscape of women's health, per UnitedHealthcare (beckerspayer.com) Ep. 188: The business case for investing in women's health The business case for investing in women’s specialty care Women’s health opportunity: Menopause symptom care [Webinar, Aug. 13] Your guide to the lab and diagnostics market landscape in 2024 A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.
In recent years, we’ve seen large retailers like CVS, Walgreens, Walmart, and even Amazon add to their care delivery portfolios, specifically through offering low-acuity primary care services. But it seems like the tide may be shifting. In April, Walmart announced that it’s shuttering its primary care operations and virtual care arm—and it’s not the only one scaling back. The fact is, a number of retailers are retrenching on primary care operations. In this episode, host Abby Burns invites Advisory Board experts Vidal Seegobin, Natalie Trebes, and Eliza Dailey to unpack exactly why Walmart and other retailers are pulling back on primary care delivery, and why the conventional explanation –"healthcare is too complex”– falls short. Links: Walmart Health is closing down. Here's what you need to know. Another one bites the dust: What Walmart's retreat from healthcare means for providers 5 trends (re)shaping site-of-care shifts 6 insights on consumer preferences in healthcare How Amazon, CVS, Walmart, and more are impacting provider pay Our Disruption playlist Ep. 130: Healthcare disruptors: Don't discount retailers [July 25] Understand your customer: Medical groups 101 A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.
Radio Advisory first started production in April 2020 to deliver timely, critical messages to healthcare professionals navigating the early days of the Covid-19 pandemic. Four years, 200+ episodes, and one million downloads later, Radio Advisory continues to bring insightful conversations and valuable insights to listeners passionate about driving positive change in healthcare. To celebrate our millionth download, host Rachel (Rae) Woods and the Radio Advisory production team revisit some of their favorite episodes over the last four years, recollect the lessons learned, and reflect on how the healthcare industry has evolved alongside us. We owe this milestone to you, our listeners. Your support and engagement have fueled and enriched our episodes, and we look forward to bringing you many more insightful conversations. Thank you! Links: Ep. 2: How COVID-19 is transforming telehealth now and in the future Ep. 35: Zeke Emanuel on the path to a vaccine (and why it's much harder than you think) Ep. 69: CEO Warner Thomas on 20 years of digital innovation at Ochsner Health Ep. 159: Ozempic, Wegovy, and our questions on weight management drugs 3 paths to the future of obesity care (and how to get there) 5 catalysts that will impact the future of weight management drugs What the headlines get wrong about weight-management medications How Cone Health added ATTR-CM screening to an existing care pathway: A TAVR example A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.
Generative AI is one of the most widely discussed topics in the industry today. There is continued excitement, mounting anxiety, and dozens of questions for health leaders to answer. While the healthcare industry has been working tirelessly to adapt to the almost unbelievable rate of change, many organizations struggle with how to ethically implement and scale Artificial Intelligence. This week, host Rachel (Rae) Woods invites Duke University Health System's Chief Information Officer, Dr. Eric Poon, to discuss how Duke has approached ethical implementation of AI—and how their efforts started long before ChatGPT existed. Throughout the conversation, they discuss the early challenges Duke faced, offer tactical guidance for successful implementation, and explain why proper governance is critical to ethical AI adoption. Links: Duke Health | Connect with your health care at Duke Health The best AI strategy isn't about AI AI in healthcare: Insights from 10 C-suite executives Ep. 180: Tom Lawry on why AI has a PR problem Using simplified clinical criteria to screen more patients for ATTR-CM Learn about Advisory Board Fellowship A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.
The healthcare industry has been rocked by the pandemic and thrown headfirst into a new era of technological and therapeutic revolution. Yet, in the midst of all this change and uncertainty, healthcare leaders are expected not just to survive, but actually drive value for their organizations, patients, and communities. The problem is, “driving value” is not only complex, but it’s also ambiguous. Leaders who talk about value across the industry may not even be talking about the same thing. So, how should the industry think about driving value and what does it take to get this right? In this episode, live from Advisory Board’s 2024 Value Summit, host Abby Burns invites Stacey Richter, healthcare entrepreneur, co-president of Aventria Health Group, and host of the Relentless Health Value podcast, to break down what “value” in healthcare actually means, where organizations go wrong, and how we can work to improve value across the industry. Links: Raising the Value Bar Virtual Summit Our Value-Based Care playlist EP358: How Health Insurance Plan Design Can Lead to Patients Sacrificing Needed Care, Their Mental Health, and (Sometimes) Buying Groceries, With Wayne Jenkins, MD | Relentless Health Value™ EP391: Lessons for Private Equity and Others Trying to Do Right by PCPs and Their Patients, With Scott Conard, MD | Relentless Health Value™ EP427: How Do Digital Health Vendors Deliver Patient Outcomes and Experiences? With Rik Renard | Relentless Health Value™ EP432: The Knifepoint Intersection of Margin and Mission and the Peril of Cutting Clinical “Waste,” With Kate Wolin, ScD | Relentless Health Value™ The challenges with migraine care — and what health systems can do about it A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.
The rise of generative AI has impacted healthcare in many ways – one of which is that it’s pushing Big Tech toward becoming not just a relevant, but a central player in the industry. And when we’re talking Big Tech, we have to include Google. Google’s activity in healthcare has been turbulent since it entered the space nearly two decades ago, but it’s impossible to deny the significance of the contributions it’s made to the industry. Now with the rapid growth of genAI, Google is refining its healthcare strategy to drive maximum impact in the areas it’s best positioned to – places like consumer, therapeutics, diagnostics, and more. At the forefront of this work is Dr. Karen DeSalvo, Google’s Chief Health Officer. This week, guest host Eric Larsen, President Emeritus of Advisory Board and President of Towerbrook Advisors sits down with Dr. DeSalvo to unpack the seemingly boundless opportunities of generative AI to evolve healthcare and the unique—and scoped—role Google is playing in helping advance that evolution. Links: Lessons from the C-suite AI in healthcare: Insights from 10 C-suite executives Ep. 197: Lessons from the C-Suite: Demystifying generative AI with Dr. John Halamka, President of Mayo Clinic Platform Ep. 185: AI adoption: why you can't afford to "wait and see" Ep. 180: Tom Lawry on why AI has a PR problem The chronic condition we should be talking about: Challenges and opportunities in migraine care Learn about Advisory Board Fellowship A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.
So far in our series on bespoke care and innovation, we’ve delved into the future of cancer care and the opportunities for equity in precision medicine. But we can’t conclude our series without talking about one of the most exciting developments in the field: cell and gene therapies. We’ve talked about these therapies on the pod before—but like everyone else, we’ve primarily focused on the payment side of the equation and looked at how purchasers and pharma can work together to ensure patient access. These conversations miss the voice of a key stakeholder: providers. What is the role of the provider organizations in realizing the value of cell and gene therapies? To answer that question, in the final episode of our series leading up to Advisory Board’s Clinical Innovation Summit: Revolutions in Specialty Care, host Rachel (Rae) Woods invites Advisory Board pharmacy experts Gina Lohr and Chloe Bakst to unpack how providers are grappling with how to get these life-changing treatments to those that need them. Links: Ep. 210: How you approach precision medicine matters—for some patients more than others Ep. 209: Predicting what oncology will look like in 2030 4 things leaders need to know about high-cost drugs 3 takeaways on why primary care is key to migraine management Register for the Revolutions in Specialty Care Summit A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.
It's no secret that healthcare is becoming more and more personalized – or “bespoke” – as increasingly sophisticated diagnostics and therapeutics continue to explode into the market. This vast pipeline is redefining the industry in several ways—but there is real risk associated if the stakeholders responsible for developing, delivering, and paying for these innovations aren’t baking health equity into their business models. Last week, in the first episode of our run up to the Advisory Board Clinical Innovation Summit: Revolutions in Specialty Care, we discussed Advisory Board’s prediction for the future of oncology. This week, host Rachel (Rae) Woods invites Advisory Board experts Amanda Okaka and Fanta Cherif to break down the health equity conundrum presented by precision medicine: Will precision medicine reduce health disparities, or exacerbate them? The answer depends on the actions—big and small—of industry leaders. Links: Register for the Revolutions in Specialty Care Summit How precision medicine can help us move from race-based to race-conscious medicine Ep. 209: Predicting what oncology will look like in 2030 Ep. 204: Unveiling "Bespoke Care": Healthcare's tailored future Bespoke care, part 1: What it is and how it’s transforming care delivery Register for the Clinical Innovation Summit A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.
There has been a lot of change in the oncology space in the last few years. These changes have brought new pressures, like workforce strain, increased competition, rising spend, and more. While many leaders are worried about the "right now," it is crucial to consider how you can best position yourself for the future of cancer care. That's why, in this episode, host Rachel (Rae) Woods invites Advisory Board specialty care experts Lindsey Paul and Julia Elder to discuss why preparing for the future means making changes today. Throughout the conversation, they discuss how current pressures are changing the field of oncology and four ways cancer care will change by 2030. Links: 4 predictions for cancer care in 2030 3 strategies to leverage oncology pharmacists and improve cancer care 5 strategies to deploy (and empower) APPs in cancer care Ep. 203: Value series: Is the future of VBC in specialty care? Zing Health & Strive Health say yes. Ep. 202: Value series: Why CenterWell (and Humana) is going all in on senior care Register for the Clinical Innovation Summit A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.
According to economist Jim Rebitzer and healthcare consultant Bob Rebitzer, the healthcare industry has failed in achieving what many other sectors have accomplished – improving products, while simultaneously reducing costs over time. In this episode, recorded live at The Players 2024 Championship, host Rachel (Rae) Woods invited Jim and Bob to discuss the central premise of their book, Why Not Better and Cheaper? They discussed the root causes of this challenge – including incentives, prevailing professional and social norms, and competition – that the industry must confront to deliver better and cheaper healthcare. Links: Learn more about the Rebitzer brothers and their new book, Why Not Better and Cheaper? Our Financial Impact playlist This spring Radio Advisory is celebrating four years of production. Thank you for listening! Truly personalized care is possible. Here's how to make it a reality. Learn about Advisory Board On-Demand Courses Learn about Advisory Board Fellowship A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.
Radio Advisory has commemorated Nurses Week every year since we started production in April 2020. A lot has changed since the early days of the pandemic, but the reality is that we’re still grappling with a workforce crisis defined by rising burnout, turnover, and shortages. Celebrating nurses just one week out of the year will not suffice in addressing these complex issues. In this episode, host Rachel (Rae) Woods sits down with Advisory Board nursing experts Monica Westhead, Allyson Paiewonsky, and Ali Knight to discuss why the industry needs to pivot towards more sustainable strategies for their care teams, what leaders should be thinking about when training and supporting nurses, and why "top-of-license care" is an incomplete solution. Links: [Webinar] How to cultivate resilient and adaptive nurse leaders 4 ways to retain early career nurses 3 underlying causes of nurse recruitment and retention challenges A detailed look at the top 2 models for virtual nursing care 3 ways AI can help nurses AI nurses? Inside Nvidia, Hippocratic AI's new partnership Our Clinical Workforce playlist Ep. 205: Live from ViVE 2024: Four leaders on how technology is redefining clinical work Ep. 162: Addressing the workforce crisis: Insights from University Hospitals' leaders Ep. 135: Henry Ford Health on nursing shortages and the real supply chain issue 6 advantages to matching patients with compatible clinicians (sponsored by Optum Match) Learn about Advisory Board Fellowship [Webinar, May 14] Bespoke care, part 1: What it is and how it’s transforming care delivery A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.
As healthcare leaders continue to contend with workforce shortages, technological shifts, and fragile financials it can be hard to predict what the future looks like for their organizations and the transformation that needs to happen to improve healthcare for all. In this episode, host Rachel (Rae) Woods invites the 24th Secretary of the U.S. Department of Health and Human Services Alex Azar to discuss what "transformation" actually means, what conditions need to be in place to mitigate financial loss, and what leaders can do to advance towards industry-wide transformation. Links: Our Value-based Care playlist Around the nation: CMS hints at more prior authorization rules Our Strategy playlist Truly personalized care is possible. Here's how to make it a reality. [Webinar, May 14] Bespoke care, part 1: What it is and how it’s transforming care delivery A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.
You might be burned out from talking about burnout. But the truth is, healthcare workers are still suffering from high administrative burden, reduced autonomy, and a cycle of turnover and retirements that we cannot escape. In response, industry leaders are looking to the latest and greatest technologies to unburden their workforce and improve the mental wellbeing of their staff. But will the promise of a tech-enabled clinical workforce live up to the hype? In this special episode, recorded live from ViVE 2024, host Rachel (Rae) Woods invites Dr. Nele Jessel, Chief Medical Officer at athenahealth, Dr. Jesse Ehrenfeld, President of the American Medical Association, Dr. Syl Trepanier, SVP and System Chief Nursing Officer at Providence, and Dr. Tina Shah, Chief Clinical Officer at Abridge, to discuss the state of the workforce crisis, how new technologies are redefining work, and why emerging technologies like AI might not be a silver bullet. Links: Cloud-Based Healthcare Products & Services | athenahealth American Medical Association (ama-assn.org) World-class health care with human connection | Providence Abridge | Generative AI for Clinical Conversations How technology can help solve the workforce crisis Truly personalized care is possible. Here's how to make it a reality. [Webinar, May 14] Bespoke care, part 1: What it is and how it’s transforming care delivery A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.
Top Podcasts
The Best New Mark Levin Podcast Right Now - March 2025The Best New VINCE Podcast Right Now - March 2025The Best New Joe Rogan Experience Podcast Right Now - March 2025The Best New Sports Podcast Right Now - March 2025The Best New Business Podcast Right Now - March 2025The Best New News Podcast Right Now - March 2025The Best New Comedy Podcast Right Now - March 2025The Best New True Crime Podcast Right Now - March 2025
Download from Google Play
Download from App Store
United States
At Micet Craft, we recognize that each brewery has unique requirements. That’s why we offer custom solutions tailored to fit your specific brewing needs. Our expert team collaborates with you to design equipment that optimizes your workflow while maintaining high quality. Whether you’re launching a startup or expanding an existing operation, Micet Craft provides the perfect brewing equipment to elevate your craft.https://www.micetcraft.com/fermentation-tank/
Thor Sound Booster
sogood voice the better peace world..♥️🎉🧿